BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29480319)

  • 1. [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
    Helf D; Schneiderbanger D; Markus CK; Johannsen S; Schuster F
    Anaesthesist; 2018 Apr; 67(4):275-279. PubMed ID: 29480319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
    Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
    J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
    Dexter F; Epstein RH; Wachtel RE; Rosenberg H
    Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
    Larach MG; Klumpner TT; Brandom BW; Vaughn MT; Belani KG; Herlich A; Kim TW; Limoncelli J; Riazi S; Sivak EL; Capacchione J; Mashman D; Kheterpal S; Kooij F; Wilczak J; Soto R; Berris J; Price Z; Lins S; Coles P; Harris JM; Cummings KC; Berman MF; Nanamori M; Adelman BT; Wedeven C; LaGorio J; McCormick PJ; Tom S; Aziz MF; Coffman T; Ellis TA; Molina S; Peterson W; Mackey SC; van Klei WA; Ginde AA; Biggs DA; Neuman MD; Craft RM; Pace NL; Paganelli WC; Durieux ME; Nair BJ; Wanderer JP; Miller SA; Helsten DL; Turnbull ZA; Schonberger RB;
    Anesthesiology; 2019 Jan; 130(1):41-54. PubMed ID: 30550426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
    Schuster F; Johannsen S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia.
    Litman RS; Smith VI; Larach MG; Mayes L; Shukry M; Theroux MC; Watt S; Wong CA
    Anesth Analg; 2019 Apr; 128(4):652-659. PubMed ID: 30768455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A suspected case of anesthesia-induced rhabdomyolysis in a child undergoing strabismus surgery.
    Leo AM; McVey MJ; Iizuka M; Richards MD
    J AAPOS; 2019 Jun; 23(3):167-169. PubMed ID: 30735783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium sulfate - An effective agent could delay the progression of fulminant malignant hyperthermia.
    Xu X
    Med Hypotheses; 2019 Mar; 124():118-120. PubMed ID: 30798905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the malignant hyperthermia syndrome.
    Rosenberg H; Fletcher JE
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):84-97. PubMed ID: 7710242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation.
    Aires CCG; de Souza RRL; Amorim JA; Santos FG; Diniz DA; Carneiro SCAS; Vasconcellos RJH
    Spec Care Dentist; 2023 Jan; 43(1):99-108. PubMed ID: 35667046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia: a potentially fatal complication of anesthesia.
    Stolworthy C; Haas RE
    Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suxamethonium-induced rhabdomyolysis in a healthy middle-aged man.
    Le Puura AI; Koivisto P; Annila P
    Acta Anaesthesiol Belg; 2000; 51(1):51-3. PubMed ID: 10806523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
    Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S
    Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model].
    Jantzen JP; Eberle B; Gaida BJ; Hennes HJ; Otto S; Schäfer M
    Anaesthesist; 1992; 41(5):248-53. PubMed ID: 1616114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 20-Year-Old-Trauma Patient With Suspected Malignant Hyperthermia Following Induction With Succinylcholine: A Case Study.
    Luckey-Smith K; High K
    Adv Emerg Nurs J; 2018; 40(3):171-175. PubMed ID: 30059371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder.
    Flick RP; Gleich SJ; Herr MM; Wedel DJ
    Paediatr Anaesth; 2007 Jan; 17(1):22-7. PubMed ID: 17184427
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.